Sartorius-Logo_BIA-separations-Logo_Part-of Sartorius

BIA Separations, a Sartorius company, develops and manufactures market-leading CIM® monolithic chromatographic columns for purification and analysis of large biomolecules, such as viruses, plasmids and mRNA, which are applied in cell and gene therapies.  BIA's technology for manufacturing-scale purification is already used in production of the first commercialized advanced therapeutics; BIA also has a keen presence with novel drug candidates in the clinical pipeline.  Expecting continued strong double-digit sales growth over the next few years, BIA earned sales revenue approx. 25 million Euros in 2020, contributing to Sartorius Bioprocess Solutions, part of the Sartorius Group.

Team Members

AS 1 2021-min

Aleš Štrancar

Managing Director

Bia-439-R-WEB-min

Marko Narobe

Sales & Product Manager

Bia D2-828 (3)-min

Nejc Pavlin

Project Leader